Crossmark

Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study

Crossref DOI link: https://doi.org/10.1007/s11764-015-0511-6

Published Online: 2016-01-19

Published Print: 2016-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Arem, Hannah

Sorkin, Mia

Cartmel, Brenda

Fiellin, Martha

Capozza, Scott

Harrigan, Maura

Ercolano, Elizabeth

Zhou, Yang

Sanft, Tara

Gross, Cary

Schmitz, Kathryn

Neogi, Tuhina

Hershman, Dawn

Ligibel, Jennifer

Irwin, Melinda L.
Funding

Funding for this research was provided by:

National Cancer Institute (R01 CA132931)

National Institutes of Health (P30 CA016359)

National Center for Advancing Translational Sciences (UL1 TR000142)
License Information

Text and Data Mining valid from 2016-01-19

Version of Record valid from 2016-01-19
More Information

Article History

Received: 30 June 2015

Accepted: 25 December 2015

First Online: 19 January 2016

Compliance with ethical standards

:

: Cary P. Gross: Research funding from 21st Century Oncology, Medtronic, Johnson & Johnson.Tara Sanft: Consulting or Advisory Role at bioTheranostics; Research funding from bioTheranostics.All other authors report no conflicts of interest.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below